558 related articles for article (PubMed ID: 36096706)
1. [A comparison of CAS risk model and CHA
Deng JL; He L; Jiang C; Lai YW; Long DY; Sang CH; Jia CQ; Feng L; Li X; Ning M; Hu R; Dong JZ; Du X; Tang RB; Ma CS
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Sep; 50(9):888-894. PubMed ID: 36096706
[No Abstract] [Full Text] [Related]
2. Risk Levels and Adverse Clinical Outcomes Among Patients With Nonvalvular Atrial Fibrillation Receiving Oral Anticoagulants.
Lip GYH; Murphy RR; Sahiar F; Ingall TJ; Dhamane AD; Ferri M; Hlavacek P; Preib MT; Keshishian A; Russ C; Rosenblatt L; Yuce H; Deitelzweig S
JAMA Netw Open; 2022 Aug; 5(8):e2229333. PubMed ID: 36044214
[TBL] [Abstract][Full Text] [Related]
3. [The thromboembolism risk of low-risk atrial fibrillation patients with different clinical characteristics].
Liu XB; Jia ZX; Xia SJ; He L; Lu SX; Guo XY; Li SN; Liu N; Jiang CX; Sang CH; Tang RB; Long DY; Yu RH; Bai R; Wu JH; Du X; Dong JZ; Ma CS
Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):735-739. PubMed ID: 32957755
[No Abstract] [Full Text] [Related]
4. Net clinical benefit of oral anticoagulants in Asian patients with atrial fibrillation based on a CHA
Methavigul K; Chichareon P; Yindeengam A; Krittayaphong R
BMC Cardiovasc Disord; 2023 Dec; 23(1):623. PubMed ID: 38114960
[TBL] [Abstract][Full Text] [Related]
5. GARFIELD-AF risk score for mortality, stroke, and bleeding within 2 years in patients with atrial fibrillation.
Fox KAA; Virdone S; Pieper KS; Bassand JP; Camm AJ; Fitzmaurice DA; Goldhaber SZ; Goto S; Haas S; Kayani G; Oto A; Misselwitz F; Piccini JP; Dalgaard F; Turpie AGG; Verheugt FWA; Kakkar AK;
Eur Heart J Qual Care Clin Outcomes; 2022 Mar; 8(2):214-227. PubMed ID: 33892489
[TBL] [Abstract][Full Text] [Related]
6. CHA
D'Souza M; Carlson N; Fosbøl E; Lamberts M; Smedegaard L; Nielsen D; Torp-Pedersen C; Gislason G; Schou M
Eur J Prev Cardiol; 2018 Apr; 25(6):651-658. PubMed ID: 29482441
[TBL] [Abstract][Full Text] [Related]
7. Thromboembolism and bleeding in patients with atrial fibrillation and liver disease - A nationwide register-based cohort study: Thromboembolism and bleeding in liver disease.
Steensig K; Pareek M; Krarup AL; Sogaard P; Maeng M; Tayal B; Lee CJ; Torp-Pedersen C; Lip GY; Holland-Fischer P; Kragholm KH
Clin Res Hepatol Gastroenterol; 2022 Oct; 46(8):101952. PubMed ID: 35609823
[TBL] [Abstract][Full Text] [Related]
8. Patients with atrial fibrillation and mid-range ejection fraction differ in anticoagulation pattern, thrombotic and mortality risk independently of CHA
Jurin I; Lucijanic M; Jurin H; Starcevic B; Varvodic J; Catic J; Jurisic A; Vitlov P; Sokol Tomic S; Lucijanic J; Hadzibegovic I
Heart Vessels; 2020 Sep; 35(9):1243-1249. PubMed ID: 32248252
[TBL] [Abstract][Full Text] [Related]
9. Stroke and bleeding risk scores in patients with atrial fibrillation and valvular heart disease: evaluating 'valvular heart disease' in a nationwide cohort study.
Lip GYH; Jensen M; Melgaard L; Skjøth F; Nielsen PB; Larsen TB
Europace; 2019 Jan; 21(1):33-40. PubMed ID: 29986001
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of risk stratification schemes for ischaemic stroke and bleeding in 182 678 patients with atrial fibrillation: the Swedish Atrial Fibrillation cohort study.
Friberg L; Rosenqvist M; Lip GY
Eur Heart J; 2012 Jun; 33(12):1500-10. PubMed ID: 22246443
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events - European Registry in Atrial Fibrillation (PREFER in AF).
Rohla M; Weiss TW; Pecen L; Patti G; Siller-Matula JM; Schnabel RB; Schilling R; Kotecha D; Lucerna M; Huber K; De Caterina R; Kirchhof P
BMJ Open; 2019 Mar; 9(3):e022478. PubMed ID: 30928922
[TBL] [Abstract][Full Text] [Related]
12. Risk of Thromboembolism in Non-Valvular Atrial Fibrillation With or Without Clinical Hyperthyroidism.
Lin YS; Tsai HY; Lin CY; Wu VC; Chen TH; Yang TY; Aboyans V; Chen MC
Glob Heart; 2021 Jun; 16(1):45. PubMed ID: 34211831
[TBL] [Abstract][Full Text] [Related]
13. The HAS-BLED score has better prediction accuracy for major bleeding than CHADS2 or CHA2DS2-VASc scores in anticoagulated patients with atrial fibrillation.
Roldán V; Marín F; Manzano-Fernández S; Gallego P; Vílchez JA; Valdés M; Vicente V; Lip GY
J Am Coll Cardiol; 2013 Dec; 62(23):2199-204. PubMed ID: 24055744
[TBL] [Abstract][Full Text] [Related]
14. Young Male Patients with Atrial Fibrillation and CHA2DS2-VASc Score of 1 May Not Need Anticoagulants: A Nationwide Population-Based Study.
Chan YH; Wu LS; Chang SH; Lee HF; Liu JR; See LC; Yeh YH; Kuo CT
PLoS One; 2016; 11(3):e0151485. PubMed ID: 26986069
[TBL] [Abstract][Full Text] [Related]
15. Pacemaker-detected atrial fibrillation burden and risk of ischemic stroke or thromboembolic events-A cohort study.
Chu SY; Jiang J; Wang YL; Sheng QH; Zhou J; Ding YS
Heart Lung; 2020; 49(1):66-72. PubMed ID: 31376922
[TBL] [Abstract][Full Text] [Related]
16. Impact of the CHA
Agudelo V; Millán X; Li CH; Asmarats L; Fernández-Peregrina E; Santaló M; Jimenez-Kockar M; Gheorghe L; Serra A; Arzamendi D
Int J Cardiol; 2020 Nov; 319():78-84. PubMed ID: 32634500
[TBL] [Abstract][Full Text] [Related]
17. Meta-analysis of CHADS2 versus CHA2DS2-VASc for predicting stroke and thromboembolism in atrial fibrillation patients independent of anticoagulation.
Zhu WG; Xiong QM; Hong K
Tex Heart Inst J; 2015 Feb; 42(1):6-15. PubMed ID: 25873792
[TBL] [Abstract][Full Text] [Related]
18. Net clinical benefit of antithrombotic therapy in patients with atrial fibrillation and chronic kidney disease: a nationwide observational cohort study.
Bonde AN; Lip GY; Kamper AL; Hansen PR; Lamberts M; Hommel K; Hansen ML; Gislason GH; Torp-Pedersen C; Olesen JB
J Am Coll Cardiol; 2014 Dec; 64(23):2471-82. PubMed ID: 25500231
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the CHA2DS2-VASc Score in Predicting Ischemic Stroke, Thromboembolism, and Death in Patients With Heart Failure With and Without Atrial Fibrillation.
Melgaard L; Gorst-Rasmussen A; Lane DA; Rasmussen LH; Larsen TB; Lip GY
JAMA; 2015 Sep; 314(10):1030-8. PubMed ID: 26318604
[TBL] [Abstract][Full Text] [Related]
20. Stroke and Thromboembolism in Warfarin-Treated Patients with Atrial Fibrillation: Comparing the CHA2DS2-VASc and GARFIELD-AF Risk Scores.
Proietti M; Rivera-Caravaca JM; Esteve-Pastor MA; Marín F; Lip GYH
Thromb Haemost; 2021 Aug; 121(8):1107-1114. PubMed ID: 33296920
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
